Comments

Tvardi Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Tvardi Therapeutics (TVRD) operate in?

Tvardi Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

TVRDNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$18.85

1.055.90%

At close: -

$18.84

-0.01-0.05%

After Hours: Apr 25, 4:40 PM EDT

Tvardi Therapeutics (TVRD) Forecast

News Earnings Tvardi Therapeutics (TVRD) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Tvardi Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:TVRD | Benzinga

Explore Tvardi Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for TVRD.

Open	$17.51
Close	$18.85
Volume / Avg.	13.75K / 31.30K
Day Range	$17.02 - $18.85
52 Wk Range	15.13 - 25.53
Market Cap	$176.26M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	-
Days to Cover	-

Recent News

Why Coursera Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	$17.51
Close	$18.85
Volume / Avg.	13.75K / 31.30K
Day Range	$17.02 - $18.85
52 Wk Range	15.13 - 25.53
Market Cap	$176.26M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	-
Days to Cover	-

About Tvardi Therapeutics Inc.

Sector

Health Care

Industry

Pharmaceuticals

Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of ...

Got Questions? Ask

What is TVRD's all-time high price?

What is TVRD's P/S ratio?

What is the consensus rating for TVRD?

What’s the latest news on TVRD?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Tvardi Therapeutics (TVRD) stock?

You can purchase shares of Tvardi Therapeutics (NASDAQ:TVRD) through any online brokerage.

View our list of the best stock brokerages

Who are Tvardi Therapeutics (TVRD) competitors?

Other companies in Tvardi Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Bioage Labs (NASDAQ:BIOA), Terns Pharma (NASDAQ:TERN) and Neumora Therapeutics (NASDAQ:NMRA).

What is the forecast, or price target, for Tvardi Therapeutics (TVRD) stock?

There is no analysis for Tvardi Therapeutics to provide a consensus price target.

What is the current price for Tvardi Therapeutics (TVRD)?

The stock price for Tvardi Therapeutics (NASDAQ: TVRD) is $18.84 last updated April 25, 2025 at 4:40 PM EDT.

Does Tvardi Therapeutics (TVRD) pay a dividend?

There are no upcoming dividends for Tvardi Therapeutics.

When is Tvardi Therapeutics (NASDAQ:TVRD) reporting earnings?

Tvardi Therapeutics’s Q4 earnings are confirmed for Wednesday, May 21, 2025.

Is Tvardi Therapeutics (TVRD) going to split?

There is no upcoming split for Tvardi Therapeutics.

What sector and industry does Tvardi Therapeutics (TVRD) operate in?

Tvardi Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.